Delaware (State or other jurisdiction of incorporation or organization) |
000-50549 (Commission File Number) |
62-1715807 (I.R.S. Employer Identification No.) |
ITEM 8.01 | Other Events. |
On March 23, 2010, Ipsen and GTx, Inc. issued a joint press release announcing that it has expanded their partnership for the development and commercialization of toremifene 80 mg for the reduction of fractures in men with advanced prostate cancer on androgen deprivation therapy (ADT) and toremifene 20 mg for the prevention of prostate cancer in high risk patients with High Grade Prostatic Intraepithelial Neoplasia lesions (HGPIN), a copy which is furnished as Exhibit 99.1 to this Current Report. |
ITEM 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits |
Exhibit | ||
Number | Description | |
99.1
|
Press Release issued by GTx, Inc. dated March 23, 2010 |
GTx, INC. |
||||
Date: March 23, 2010 | By: | /s/ Henry P. Doggrell | ||
Name: | Henry P. Doggrell | |||
Title: | Vice President, General Counsel and Secretary |
Exhibit | ||
Number | Description | |
99.1 |
Press Release issued by GTx, Inc. dated March 23, 2010 |